Premium Subscribers: Complete your KYC to Avoid
Service Suspension. Login Here.

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CONCORD BIOTECH Gains 9%; BSE HEALTHCARE Index Down 1.0%
Fri, 6 Feb 11:45

CONCORD BIOTECH Gains 9%; BSE HEALTHCARE Index Down 1.0%Image source: alexsl/www.istockphoto.com

CONCORD BIOTECH share price has zoomed 9% and is presently trading at Rs 1,267.2.

Meanwhile, the BSE HEALTHCARE index is at 41,753.3 (down 1.0%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 3.3%) and METROPOLIS HEALTHCARE (up 2.3%).

POLY MEDICURE (down 6.5%) and COHANCE LIFESCIENCES (down 5.0%) are among the top losers today.

Over the last one year, CONCORD BIOTECH has moved down from Rs 2,238.8 to Rs 1,267.2, registering a loss of Rs 971.6 (down 43.4%).

On the other hand, the BSE HEALTHCARE index has moved down from 42,560.8 to 41,753.3, registering a loss of 1.9% during the last 12 months.

The top losers among the BSE HEALTHCARE index stocks during this same period were COHANCE LIFESCIENCES (down 70.1%), POLY MEDICURE (down 42.0%) and SYNGENE INTERNATIONAL (down 39.6%).

Peak India: The Rally of the Past 5 Years was Just a Preview

What About the Benchmark Indices?

The BSE Sensex is at 83,332.3 .

The top gainers among the BSE Sensex today are ITC (up 4.5%) and Kotak Bank (up 2.9%). The most traded stocks in the BSE Sensex are ITC and Tata Motors.

In the meantime, NSE Nifty is at 25,627.9 (down 0.1%). TCS and SBI LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 78,583.8 to 83,332.3, registering a gain of 4,748.5 points (up 6.0%).

CONCORD BIOTECH Financial Update...

CONCORD BIOTECH net profit fell 38.4% YoY to Rs 608 million for the quarter ended September 2025, compared to a profit of Rs 987 million a year ago. Net sales declined 20.4% to Rs 2,471 million during the period as against Rs 3,102 million in July-September 2024.

For the year ended March 2025, CONCORD BIOTECH reported 20.6% increase in net profit to Rs 3,716 million compared to net profit of Rs 3,081 million during FY24. Revenue of the company grew 18.0% to Rs 12,001 million during FY25.

The current Price to earnings ratio of CONCORD BIOTECH, based on rolling 12 month earnings, stands at 41.5.


Equitymaster requests your view! Post a comment on "CONCORD BIOTECH Gains 9%; BSE HEALTHCARE Index Down 1.0%". Click here!